-- European equities traded in the US as American depositary receipts were trending lower late Thursday morning, declining 0.42% to 1,823.55 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and internet browser company Opera (OPRA), which advanced 4.4% and 3.7%, respectively. They were followed by petroleum refiner Equinor (EQNR) and software firm SAP (SAP), which increased 3.6% and 3.1%, respectively.
The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and biotech firm Evaxion (EVAX), which dropped 3% and 1.6%, respectively. They were followed by biopharmaceutical companies DBV Technologies (DBVT) and argenx (ARGX), which fell 1.3% and 1.1%, respectively.
The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and communications company WPP (WPP), which rose 4.3% and 2.8%, respectively. They were followed by educational publisher Pearson (PSO) and oil and gas company BP (BP), which were up 2.4% and 2.1%, respectively.
The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and biopharmaceutical company Bicycle Therapeutics (BCYC), which lost 4.6% and 2.8%, respectively. They were followed by biopharmaceutical company NuCana (NCNA) and pharmaceutical company GSK (GSK), which were down 1.7% and 0.9%, respectively.